Literature DB >> 3389048

Studies on thyroid activity in deoxycorticosterone-salt and Goldblatt two-kidney, one-clip hypertensive rats.

F Vargas1, C Garcia del Rio, J D Luna, J M Haro, C Osorio.   

Abstract

In this paper we studied the role of thyroid gland function in two experimental hypertension models with different pathophysiological mechanisms: deoxycorticosterone-salt (DOCA-salt, volume dependent) and Goldblatt 2-kidney, 1-clip (2K1C, renin dependent). DOCA-salt hypertensive rats showed lower T3 and T4 serum levels by the third week of induced hypertension. Goldblatt 2K1C hypertensive rats, however, exhibited normal values for both hormones. Treatment with thyroxine accelerated the evolution of hypertension and did not affect the PRA of DOCA-salt rats. Radiothyroidectomy inhibited DOCA-salt and Goldblatt 2K1C hypertension, and prevented the suppression of PRA in DOCA-salt rats, without altering PRA or serum aldosterone in Goldblatt 2K1C rats. These results suggest that: a) a thyroid depressing factor is not activated in Goldblatt 2K1C rats; b) thyroidectomy interferes with the suppressor effect of mineralocorticoid on renin secretion; and c) normal thyroid activity is required for the hypertensive effect of the renin-angiotensin-aldosterone system in Goldblatt 2K1C rats.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3389048     DOI: 10.1530/acta.0.1180022

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  2 in total

1.  Effects of clofibrate on salt loading-induced hypertension in rats.

Authors:  Antonio Cruz; Isabel Rodríguez-Gómez; Rocío Pérez-Abud; Miguel Ángel Vargas; Rosemary Wangensteen; Andrés Quesada; Antonio Osuna; Juan Manuel Moreno
Journal:  J Biomed Biotechnol       Date:  2010-10-14

2.  Methimazole treatment reduces cardiac hypertrophy and mortality without a concomitant reduction in blood pressure in established Goldblatt two-kidney one clip hypertension.

Authors:  F Vargas; M A Castillo; J M Haro
Journal:  Experientia       Date:  1992-08-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.